204 related articles for article (PubMed ID: 33323360)
21. Cancer Epidemiology in Hispanic Populations: An Analysis of Funded Observational Research at the National Cancer Institute.
Elena JW; Gallicchio L; Pottinger CA; Akif KE; Hanisch R; Kennedy AE; Lai GY; Mahabir S; Martin DN; Srinivasan S; Yu CT; Lam TK
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):653-658. PubMed ID: 36827212
[TBL] [Abstract][Full Text] [Related]
22. Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges.
Gallicchio L; Daee DL; Rotunno M; Barajas R; Fagan S; Carrick DM; Divi RL; Filipski KK; Freedman AN; Gillanders EM; Lam TK; Martin DN; Rogers S; Verma M; Nelson SA
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1305-1311. PubMed ID: 33795213
[TBL] [Abstract][Full Text] [Related]
23. Health Literacy Research Funded by the NIH for Disease Prevention.
Villani J; Trivedi N
Health Lit Res Pract; 2020 Nov; 4(4):e212-e223. PubMed ID: 33170287
[TBL] [Abstract][Full Text] [Related]
24. Survivorship Science at the NIH: Lessons Learned From Grants Funded in Fiscal Year 2016.
Rowland JH; Gallicchio L; Mollica M; Saiontz N; Falisi AL; Tesauro G
J Natl Cancer Inst; 2019 Feb; 111(2):109-117. PubMed ID: 30657942
[TBL] [Abstract][Full Text] [Related]
25. Healthcare delivery research in older adults with cancer: A review of National Institutes of Health-funded projects.
Sun V; Tuovinen P; Jacobsen PB; Smith AW
J Am Geriatr Soc; 2023 Jul; 71(7):2250-2255. PubMed ID: 36896874
[TBL] [Abstract][Full Text] [Related]
26. Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?
Simonds NI; Ghazarian AA; Pimentel CB; Schully SD; Ellison GL; Gillanders EM; Mechanic LE
Genet Epidemiol; 2016 Jul; 40(5):356-65. PubMed ID: 27061572
[TBL] [Abstract][Full Text] [Related]
27. The current state of funded NIH grants in implementation science in genomic medicine: a portfolio analysis.
Roberts MC; Clyne M; Kennedy AE; Chambers DA; Khoury MJ
Genet Med; 2019 May; 21(5):1218-1223. PubMed ID: 31048814
[TBL] [Abstract][Full Text] [Related]
28. Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).
Massett HA; Mishkin G; Moscow JA; Gravell A; Steketee M; Kruhm M; Han SH; Barry B; Montello M; Zwiebel J; Abrams JS; Doroshow JH; Ivy SP
Clin Cancer Res; 2019 Dec; 25(23):6925-6931. PubMed ID: 31439585
[TBL] [Abstract][Full Text] [Related]
29. Opportunities for Cancer Health Care Disparities and Care Delivery Research: An Analysis of the NCI Health Care Delivery Research Program Portfolio.
Adjei BA; White DP; McCarthy S; Priede LM; Baker M; Kent EE; Weaver SJ; Geiger AM
J Health Care Poor Underserved; 2021; 32(3):1475-1492. PubMed ID: 34421044
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio.
Yu JB; Beck TF; Anscher MS; Baschnagel AM; Brock KK; Carlson DJ; Dominello MM; Kimple RJ; Knisely JP; Mendonca MS; Mian OY; Singh AK; Moros EG; Keen JC
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):297-304. PubMed ID: 30647006
[TBL] [Abstract][Full Text] [Related]
31. NIEHS extramural global environmental health portfolio: opportunities for collaboration.
Drew CH; Barnes MI; Phelps J; Van Houten B
Environ Health Perspect; 2008 Apr; 116(4):421-5. PubMed ID: 18414621
[TBL] [Abstract][Full Text] [Related]
32. Translational research in cancer genetics: the road less traveled.
Schully SD; Benedicto CB; Gillanders EM; Wang SS; Khoury MJ
Public Health Genomics; 2011; 14(1):1-8. PubMed ID: 20051673
[TBL] [Abstract][Full Text] [Related]
33. The Relationship Between OREF Grants and Future NIH Funding Success.
Hegde V; Johansen D; Park HY; Zoller SD; Hamad C; Bernthal NM
J Bone Joint Surg Am; 2017 Aug; 99(16):e87. PubMed ID: 28816904
[TBL] [Abstract][Full Text] [Related]
34. Disproportionally low funding for trauma research by the National Institutes of Health: A call for a National Institute of Trauma.
Glass NE; Riccardi J; Farber NI; Bonne SL; Livingston DH
J Trauma Acute Care Surg; 2020 Jan; 88(1):25-32. PubMed ID: 31389923
[TBL] [Abstract][Full Text] [Related]
35. National cancer institute perspectives.
Wong RS; Brechbiel MW
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S96-9. PubMed ID: 16979449
[TBL] [Abstract][Full Text] [Related]
36. National Cancer Institute funding for rapid cycle interventional research in cancer care delivery.
Norton WE; Neta G; Jacobsen PB
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37862246
[TBL] [Abstract][Full Text] [Related]
37. Opportunities for small nutrition-related cancer research grants (R03) from the National Cancer Institute.
Nicastro HL; Seifried HE; Milner JA
J Nutr; 2011 Oct; 141(10):1765-8. PubMed ID: 21865560
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the NIH-supported sickle cell disease research portfolio.
Gavini N; Hoots WK; Mensah GA; Hanspal M
Blood Cells Mol Dis; 2015 Feb; 54(2):198-205. PubMed ID: 25466208
[TBL] [Abstract][Full Text] [Related]
39. Research Gets Funding Boost for FY 2023.
Cancer Discov; 2023 Mar; 13(3):520. PubMed ID: 36637355
[TBL] [Abstract][Full Text] [Related]
40. The potential of AI in cancer care and research.
Sharpless NE; Kerlavage AR
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188573. PubMed ID: 34052390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
